Navigation Links
Amerigen Pharmaceuticals and VIWA Pharmaceutical Company Today Jointly Announce the Signing of a Memorandum of Understanding (MOU) Setting Out Their Intention to Establish a Joint Venture to Develop and Register a Range of Branded Generic Medicines
Date:1/11/2012

Pharmaceuticals Inc., based in East Brunswick, NJ, USA. The group's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Limited, is located in Suzhou, Jiangsu Province. The group has an active portfolio of products under development, filed, or intended for filing, as ANDA's with the US FDA and the Chinese SFDA. Amerigen's focus is orally delivered products that are challenging to develop, require specialized technologies or high containment to manufacture, and present complex regulatory and intellectual property obstacles to bring to market. All Amerigen's products are developed and manufactured by the company or its partners around the world to meet the highest quality standards, including the US FDA.

About VIWA
VIWA Pharmaceutical Company Limited is a member of the VIWA group of companies and is focused on the development, registration and commercialization of finished pharmaceutical products within China and for export to other markets. The VIWA group of companies also includes the Hangzhou VIWA Company Limited, a leading provider of active pharmaceutical ingredients, fine chemicals and intermediates to the global pharmaceutical, agrochemical and animal health industries.


'/>"/>
SOURCE Amerigen Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products
2. Amerigen Pharmaceuticals and Stason Pharmaceuticals Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products
3. Amerigen Pharmaceuticals and the Shanghai Fosun Omni Pharmaceutical Company Enter Into Collaboration Agreement for the Development of Generic Oral Controlled Release Products
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
(Date:8/29/2014)... Medina Medical announced today that Mr. Engelson ... Board of Directors on August 18, 2014. Mr. Engelson ... experience, including over a decade of direct experience in ... Partner of the medical device incubator The Foundry, after ... start-ups. Mr. Engelson previously served as the Chief Financial ...
(Date:8/29/2014)... Aug. 29, 2014  BC Technical, the nation,s leading ... Medical Imaging, a leader in sales, service and installation ... allows BC Technical to continue to expand their resources ... and CT modalities. "We are committed ... Mark Alvarez , president and CEO of BC Technical. ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2
... PDL BioPharma, Inc. (PDL, the Company) (NASDAQ: PDLI ... aggregate principal amount of its 3.75% Convertible Senior Notes due ... conversion rate will initially be 126.2985 shares of common stock ... conversion price of approximately $7.92 per share of common stock. ...
... May 10, 2011 Cardica, Inc. (Nasdaq: CRDC ... and nine months ended March 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... diligently to bring our first anticipated commercial microcutter device, the ...
Cached Medicine Technology:PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 2PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 3PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 2Cardica Announces Fiscal 2011 Third Quarter Financial Results 3Cardica Announces Fiscal 2011 Third Quarter Financial Results 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 5Cardica Announces Fiscal 2011 Third Quarter Financial Results 6
(Date:9/1/2014)... City, NY (PRWEB) September 02, 2014 ... Brinkley, Office Manager at Gibson Orthopedics ... Woman of the Year. Ms. Brinkley is recognized ... administration. As the largest, most-recognized networking organization of ... and profession, the National Association of Professional Women ...
(Date:9/1/2014)... a well is drilled, fitted with a hand pump, ... for the first time? Half of them break down ... sufficient resources and training, these wells would be rendered ... North Carolina-Chapel Hill,s (UNC) Water Institute and Water and ... if local water communities collect fees for repairs and ...
(Date:9/1/2014)... UWDress.com, a well-known wedding dress manufacturer and retailer, ... bridesmaid dresses for its new and old clients. ... online category. What’s more, they are offered at very ... is specially launched to celebrate the coming of autumn. ... won great appreciation from worldwide clients. Now, the company ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to 2020? provides ... The report provides value, in millions of US dollars, ... within market segments –,     Synthetic Meshes ...     Composite Meshes and Biological Meshes. , Hernia ... of a hernia (a bulging of internal organs or ...
(Date:9/1/2014)... may be bad for your waistline. TV viewers ate ... excerpt from a Hollywood action film than those watching ... for helping Americans to gain weight because it encourages ... been on the medium and not the message. TV ... to eat more, including reading, listening to the radio ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Laura Brinkley, Manager, Gibson Orthopedics Pain Treatment & Cardiology Clinic, a 2014 Professional Woman of the Year 2Health News:The key to drilling wells with staying power in the developing world 2Health News:The key to drilling wells with staying power in the developing world 3Health News:2014 Lime Green Bridesmaid Dresses Offered At UWDress.com 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Research letter: Viewers ate more while watching Hollywood action flick on TV 2
... Percutaneous coronary intervention (PCI) may be a reasonable alternative ... left main coronary artery, according to a study that ... stents and bypass surgery were used to restore blood ... treated with stenting were more likely to need a ...
... LA JOLLA, Calif., March 31 Gamma ... disease animal model efficacy,studies, according to research ... )., Presented by Steven Wagner, Ph.D., ... Keystone Symposium on Alzheimer,s Disease, data,demonstrated that ...
... Gifts and Extra Vacation Days Motivate Employees to Run on Their ... and Put Out Their Cigarettes, College Grads Are More Likely to Enroll in ... Practices Should Be ... Covered by Insurance, NEW YORK, March 31 As wellness programs grow in,popularity, ...
... COSTA MESA, Calif., March 31 CNS ... the implementation of its,agreement to roll out ... behavioral health organization (MBHO). This,agreement enables psychiatrists ... utilize,CNS Response,s rEEG medication guidance to treat ...
... 31 Cardiac Science,Corporation (Nasdaq: CSCX ... diagnosis,resuscitation, rehabilitation, and informatics products, announced today ... that it completed,certification for its HeartCentrix(R) ECG ... is a leading developer and provider,of computer-based ...
... Increased 89.39% to $15.91 million. ... $6.08 million., - FY 2007 Net Income was $6.12 million ... - Teleconference to Be Held at 9:00 ... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI - News), (the "Company") ...
Cached Medicine News:Health News:Study finds support for PCI in unprotected left main disease 2Health News:Study finds support for PCI in unprotected left main disease 3Health News:Gamma Secretase Modulators Show Promise in Alzheimer's Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics 2Health News:Gamma Secretase Modulators Show Promise in Alzheimer's Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics 3Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 2Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 3Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 4Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 3Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 4Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 2Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 3Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 4Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 2Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 3Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 4Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 5Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 6Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 7Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 8Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 9Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 10Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 11Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 12Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 13
Semmes Spinal Fusion Curettes, length 9" (229 mm), ring size 4 x 7 mm....
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings....
Microsect Curette with increased cutting edge and modified shaft, 10"....
Bone Curette, 145 mm...
Medicine Products: